Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038982
Filing Date
2025-08-07
Accepted
2025-08-07 17:05:04
Documents
90
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dna-20250630.htm   iXBRL 10-Q 1474893
2 EX-10.1 dna-20250630xex101.htm EX-10.1 22239
3 EX-10.2 dna-20250630xex102.htm EX-10.2 34160
4 EX-31.1 dna-20250630xex311.htm EX-31.1 11606
5 EX-31.2 dna-20250630xex312.htm EX-31.2 11861
6 EX-32.1 dna-20250630xex321.htm EX-32.1 5799
7 EX-32.2 dna-20250630xex322.htm EX-32.2 6150
  Complete submission text file 0001628280-25-038982.txt   8817749

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20250630.xsd EX-101.SCH 59679
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dna-20250630_cal.xml EX-101.CAL 74281
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20250630_def.xml EX-101.DEF 413527
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20250630_lab.xml EX-101.LAB 712828
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20250630_pre.xml EX-101.PRE 579740
93 EXTRACTED XBRL INSTANCE DOCUMENT dna-20250630_htm.xml XML 1357597
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40097 | Film No.: 251195218
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)